awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30248842-2AD587BE-5C97-47D7-A85B-CD207CDFB585
Q30248842-2AD587BE-5C97-47D7-A85B-CD207CDFB585
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248842-2AD587BE-5C97-47D7-A85B-CD207CDFB585
The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.
P2860
Q30248842-2AD587BE-5C97-47D7-A85B-CD207CDFB585
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248842-2AD587BE-5C97-47D7-A85B-CD207CDFB585
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be98a39651346ff8e203bdb6c936d826d84e7ac3
P2860
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.